Q&A and closing remarks

5 More presentations in this session

Welcome and introduction

Professor M. Sharma (Hamilton, CA)

Epidemiology of stroke and disease burden

Professor M. Blomstrom-Lundqvist (Orebro, SE)

Uncovering the unmet need for patients: - with atrial fibrillation at risk of stroke - acute non-cardioembolic ischemic stroke or high-risk TIA

Professor M. Blomstrom-Lundqvist (Orebro, SE) Professor M. Sharma (Hamilton, CA)

Evolution of FXI(a) as a target for antithrombotic therapy

Doctor J. Weitz (Hamilton, CA)

Outlining the clinical evidence landscape for FXI(a) inhibition: - stroke and bleeding prevention for patients with AF at risk of stroke - secondary stroke prevention in acute non-cardioembolic ischemic stroke or high-risk TIA

Professor J. De Groot (Amsterdam, NL) Professor M. Sharma (Hamilton, CA)